Sway Medical's Concussion Management System Gains FDA Clearance
Sway Medical, Inc. has received FDA 510(k) clearance for its comprehensive concussion management system, announced in a press release. This clearance recognizes Sway as the first fully integrated tool combining both cognitive and balance testing for concussion management.
The system transforms any mobile device into a Class II medical device, utilizing patented algorithms and advanced motion analysis technology. This allows healthcare professionals to assess, track, and manage concussions with enhanced accuracy and efficiency. The platform aligns with the latest concussion management guidelines, providing a complete and objective approach to concussion care.
Sway Medical's solution is designed to fit seamlessly into medical workflows, offering a fast and easy-to-use tool for concussion assessment. With this FDA clearance, Sway Medical solidifies its position as a leader in digital health innovation, equipping healthcare professionals and sports organizations with cutting-edge tools for concussion management.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Masimo Gets FDA Clearance for AFib Detection on Radius VSM
Coreline Soft Receives FDA Clearance for Aortic CT Analysis Software
CureMD Earns ISO/IEC 42001 Certification for AI Management
FDA Clears RIVANNA BoneEnhance Software for Accuro XV
Stryker Plans $400 Million CMR Surgical Investment
Daily AI Brief: the AI news that matters, in your inbox.